0000905718-16-001715.txt : 20161026 0000905718-16-001715.hdr.sgml : 20161026 20161026130344 ACCESSION NUMBER: 0000905718-16-001715 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161026 DATE AS OF CHANGE: 20161026 EFFECTIVENESS DATE: 20161026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Variant Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001613083 IRS NUMBER: 465188564 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-261821 FILM NUMBER: 161952063 BUSINESS ADDRESS: STREET 1: 2200 N. COMMERCE PARKWAY STREET 2: SUITE 200 CITY: WESTON STATE: FL ZIP: 33326 BUSINESS PHONE: 954-931-2075 MAIL ADDRESS: STREET 1: 2200 N. COMMERCE PARKWAY STREET 2: SUITE 200 CITY: WESTON STATE: FL ZIP: 33326 D/A 1 primary_doc.xml X0707 D/A LIVE 0001613083 Variant Pharmaceuticals, Inc. 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 954-931-2075 FLORIDA None None Corporation true 2014 Stephen C Glover 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Executive Officer Director Shawn M Titcomb 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Director Nico Pronk 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Director Aaron Greenblatt 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Director Jules Musing 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 Director Pharmaceuticals Decline to Disclose 06b true 0000905718-16-001361 2016-03-11 false true true Convertible Promissory Notes false 0 4000000 1505000 2495000 false 21 0 true 0 true 0 true Some of the proceeds will be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. false Variant Pharmaceuticals, Inc. /s/ Stephen C. Glover Stephen C. Glover CEO 2016-10-26